Nanobiosym

Nanobiosym

Nanotechnology Research

Cambridge, MA 2,497 followers

About us

Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of its proprietary technology platform, that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health. To maximize global humanitarian impact, we have spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.

Industry
Nanotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, MA
Type
Privately Held
Founded
2004
Specialties
Nanotechnology and Nanotechnology-enabled devices for various industries

Locations

Employees at Nanobiosym

Updates

  • Nanobiosym reposted this

    View profile for Dr. Anita Goel, MD, PhD, graphic

    Chairman & CEO Nanobiosym R&D Institute and Nanobiosym Diagnostics, Inc ; Harvard-MIT Physicist, Physician-Scientist; Humanitarian, Visionary

    Today we mourn the loss of a great visionary and leader #RNTata2000 I will forever cherish my interactions with him which left a mark on me that indeed one can achieve pioneering science, tech, biz goals & humanitarian impact all at the same time. https://lnkd.in/ezFcFz4P

    • No alternative text description for this image
  • Nanobiosym reposted this

    View profile for Dr. Anita Goel, MD, PhD, graphic

    Chairman & CEO Nanobiosym R&D Institute and Nanobiosym Diagnostics, Inc ; Harvard-MIT Physicist, Physician-Scientist; Humanitarian, Visionary

    It was a true delight to chair the Keynote plenary session at ions 2024 My title was “does physics need a revolution to explain life and consciousness” I very much enjoyed my conversations on our panel with Hal Puthoff, Dean Radin and Thomas Brophy And delighted that we could share perspectives from Basil Hiley and Nobel Laureate Roger Penrose on these foundational questions in physics via Paul Howard’s upcoming Hollywood movie- a sequel to Infinite Potential https://lnkd.in/eZMYfZ9G

  • View organization page for Nanobiosym, graphic

    2,497 followers

    It has been our deep honor and pleasure at Nanobiosym to partner with the FDA in transforming the Digital Diagnostics Landscape

    View organization page for FDA, graphic

    780,724 followers

    The FDA's Diagnostic Data Program has achieved significant milestones in the past year, including: · Worked across the interagency and with external stakeholders to improve the quality and utility of diagnostic data, as well as its flow between individuals and institutions who need it. · Provided enhanced regulatory support and guidance to ensure that new and advanced diagnostic technologies will be safe, effective, and timely in their introduction to the U.S. market. · Supported projects with collaborating institutions and investigators including allocating approximately $100M to extramural teams for projects that advance the FDA’s mission and goals. · Driven improvements in data quality from over-the-counter, point-of-care, and lab-based diagnostic tests that help inform patient care, population health, and regulatory decision-making. · Developed a regulatory data sandbox to facilitate the development of analytical tools to support regulatory review, starting with specific use cases that integrate both new (e.g., real-world data) and traditional sources of data. Check out our latest update and learn more about opportunities for engagement, including applying for future funding. https://lnkd.in/echbbAVY

    • No alternative text description for this image

Similar pages

Browse jobs